4 Panel on Mandatory Testing at Day 2 of O’Cannabiz Vancouver on Dec 11 2018

Home > AHA Media, Cannabis, Community Engagement, O'Cannabiz, O'Cannabiz Vancouver, Vancouver > 4 Panel on Mandatory Testing at Day 2 of O’Cannabiz Vancouver on Dec 11 2018

4 Panel on Mandatory Testing at Day 2 of O’Cannabiz Vancouver on Dec 11 2018

December 24, 2018 ahamedia

MANDATORY TESTING LIMITS, QUALITY ASSURANCE & CONTROL

In this video: Av Singh, Dr. John Coleman, Dr. Brigitte Simons, Jodi McDonald, Dr. Kaveh Kahen, Barinder Rasode

The stringency of the Canadian Cannabis Act enforcing product compliance to set testing guidelines is being evaluated by the global marketplace. In this session, industry leaders will talk about the challenges and tactical execution of how products are tested and reported to pass compliance for lot release. There is opportunity to minimize risk in the analytical variance of cannabis product testing between labs and to better understand standardization for potency, pesticide quantification and trace contaminant investigations lending to higher value product development. Our experts will impart a series of “frequently asked questions” and solutions that will lend to practical information to increase your ability to stay within the regulatory lines, and give your customers a quality assured product. Moderated by: Av Singh

Panelists:

Av Singh
Cannabis Cultivation Advisor, Flemming & Singh Cannabis Inc., Chief Science Officer, Green Gorilla

Dr. John Coleman
Co-Founder & President, Anandia

Dr. Brigitte Simons
VP of Laboratories and Operations, Molecular Science Corp

Jodi McDonald
Founder & President, Keystone Labs

Dr. Kaveh Kahen
Co-Founder and CEO, Sigma Analytical Services

Barinder Rasode
Founder, NICHE, CEO, Grow Tech Labs